CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Champions Oncology, Inc.  (CSBR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Champions Oncology's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

CSBR Gross Margin (Jan 31 2017)
III. Quarter
(Oct 31 2016)
II. Quarter
(Jul 31 2016)
I. Quarter
(Apr 30 2016)
IV. Quarter
(Jan 31 2016)
III. Quarter
Y / Y Revenue Change 39.69 % 50.02 % 30.05 % -12.44 % 39.53 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 818 # 612 # 668 # 63 # 667
Seq. Revenue Change -20.01 % 21.44 % 29.36 % 11.17 % -14.1 %
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2016 Gross Margin
Champions Oncology, Inc. experienced contraction in Gross Profit by -20.01 % to $4 millions and Revenue by -20.01 %, while Gross Margin fell to 100 % a new company low.

Observing third quarter 2016 results within Biotechnology & Drugs industry 46 other companies have achieved higher Gross Margin. While Gross Margin overall ranking has deteriorated compare to previous quarter from 612 to 818.
Learn about Gross Margin
CSBR's Gross Margin third quarter 2016 Company Ranking
Within: No.
Industry # 47
Sector # 147
S&P 500 # 818

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jan 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Champions Oncology's (Jan 31 2017) Gross Profit $ 4 CSBR's Income Statement
Champions Oncology's (Jan 31 2016) Gross Profit $ 3 Quarterly CSBR's Growth
CSBR's Profits by Division See CSBR's Profits by Segment

Other Gross Margin Profitability Ratios
CSBR's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
CSBR's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for CSBR's Competitors
Gross Margin Profit Margin for Champions Oncology's Suppliers
Gross Margin Profit Margin for CSBR's Customers

You may also want to know
CSBR's Annual Growth Rates CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Gross Profit Growth
CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jan 31 2017, within Biotechnology & Drugs Industry Gross MarginJan 31 2017 MRQ Gross ProfitJan 31 2017 MRQ Revenue
Skinvisible Inc  137.22 %$ 0.035 $ 0.026 
Voyager Therapeutics, Inc.  114.23 %$ 2.698 $ 2.362 
Pdl Biopharma, Inc.  102.93 %$ 68.441 $ 66.492 
Biotime Inc  101.84 %$ 1.105 $ 1.085 
Intellia Therapeutics, Inc.  100.00 %$ 5.627 $ 5.627 
Mymetics Corp  100.00 %$ 0.346 $ 0.346 
Myokardia Inc  100.00 %$ 28.550 $ 28.550 
Northsight Capital, Inc.  100.00 %$ 0.004 $ 0.004 
Momenta Pharmaceuticals Inc  100.00 %$ 34.195 $ 34.195 
Nantkwest, Inc.  100.00 %$ 0.014 $ 0.014 
Kite Pharma, Inc.  100.00 %$ 4.907 $ 4.907 
Enzon Pharmaceuticals, Inc.  100.00 %$ 0.853 $ 0.853 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.832 $ 0.832 
Dimension Therapeutics, Inc.  100.00 %$ 4.132 $ 4.132 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Green Meadow Products, Inc.  100.00 %$ 0.005 $ 0.005 
Novavax Inc  100.00 %$ 5.399 $ 5.399 
Juno Therapeutics, Inc.  100.00 %$ 21.153 $ 21.153 
La Jolla Pharmaceutical Co  100.00 %$ 0.085 $ 0.085 
Oncobiologics, Inc.  100.00 %$ 0.303 $ 0.303 
Tg Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Tracon Pharmaceuticals, Inc.  100.00 %$ 0.617 $ 0.617 
Vistagen Therapeutics, Inc.  100.00 %$ 1.250 $ 1.250 
Wave Life Sciences Ltd.  100.00 %$ 0.676 $ 0.676 
Acceleron Pharma Inc  100.00 %$ 3.370 $ 3.370 
Xenetic Biosciences, Inc.  100.00 %$ 3.000 $ 3.000 
Sangamo Therapeutics, Inc  100.00 %$ 8.922 $ 8.922 
Repros Therapeutics Inc.  100.00 %$ 0.005 $ 0.005 
Opiant Pharmaceuticals, Inc.  100.00 %$ 13.535 $ 13.535 
Cytrx Corp  100.00 %$ 0.100 $ 0.100 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
CRYW's Profile
Stock Price
CRYW's Financials
CRYW's Expectations
Business Description
Fundamentals
Charts & Quotes
CRYW's News
Suppliers
CRYW's Competitors
Customers & Markets
Economic Indicators
CRYW's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com